Antibody-conjugated magnetic nanoparticles and superconducting quantum interference device sensors may provide a useful, viable and highly-sensitive alternative to mammographic screening in breast tumor cell detection.
Tetsushi Taguchi of the International Center for Materials Nanoarchitectonics (MANA) in Japan gives a comprehensive overview of the key technologies and materials required for the regeneration of organs. This review emphasizes the importance of the development of methods for the assembly and adhesion between individual cells and/or vesicles for in vitro regeneration of organs.
Imec and its 16 project partners have announced that they have launched the European FP7 project X10D, a project aimed at developing tandem organic solar cells with an increased conversion efficiency and lifetime, and a decreased production cost. The ultimate goal of the X10D project is to bring organic photovoltaic technologies (OPV) towards introduction into the competitive thin-film PV market.
A research team at the University of Alberta wants to refine the optical transmission of information by using a single photon, the fundamental building block of light that can allow unprecedented applications in optical information transfer.
Stir this clear liquid in a glass vial and nothing happens. Shake this liquid, and free-floating sheets of protein-like structures emerge, ready to detect molecules or catalyze a reaction. This isn't the latest gadget from James Bond's arsenal -- rather, the latest research from the Berkeley Lab scientists unveiling how slim sheets of protein-like structures self-assemble.
A group of researchers has devised a unique experiment to mimic the natural process of biomineralization in order to create oriented gold nanocrystals and examine their formation at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) at Argonne National Laboratory.
Scientists report what they believe is the first pre-clinical demonstration of the potential of molecularly targeted nanoparticles as a promising new class of agents that can improve chemoradiotherapy treatment.